Anticoagulation use and Hemorrhagic Stroke in SARS-CoV-2 Patients Treated at a New York Healthcare System
Alexandra Kvernland(NYU Langone Health), Kara Melmed(NYU Langone Health), Seena Dehkharghani(NYU Langone Health), Maksim Shapiro(Barrow Neurological Institute), Shadi Yaghi, Ariane Lewis(New York University), Brian Mac Grory(Duke University), Nils Henninger(UMass Memorial Health Care), Jose Torres(Norwegian Womens Public Health Association), Adam de Havenon(Yale University), Howard A. Riina(NYU Langone Health), Peter Kim Nelson(NYU Langone Health), Barry Czeisler(NYU Langone Health), Koto Ishida(Norwegian Womens Public Health Association), Aaron Lord(Norwegian Womens Public Health Association), Omar Tanweer(Baylor College of Medicine), Jennifer Frontera(Norwegian Womens Public Health Association), Erez Nossek(NYU Langone Health), D. Ethan Kahn(NYU Langone Health), Ting Zhou(Yale University), David Gordon(NYU Langone Health), Rajan Jain(NYU Langone Health), Arooshi Kumar(NYU Langone Health), Eytan Raz(NYU Langone Health)
Cited by 77
Related Papers
A Randomized Trial of Low-Dose Aspirin in the Primary Prevention of Cardiovascular Disease in Women
|New England Journal of Medicine|2005|2k
Vitamin D Supplements and Prevention of Cancer and Cardiovascular Disease
|New England Journal of Medicine|2018|1.6k
Diverse functional autoantibodies in patients with COVID-19
|Nature|2021|984
Marine n−3 Fatty Acids and Prevention of Cardiovascular Disease and Cancer
|New England Journal of Medicine|2018|961